Bile Duct Cancer Market 2018 – Global Trend in Healthcare Industry by Top 10 Players Analysis and Forecasts Till 2023 | Asserts MRFR

Market Research Future published a Premium Research Report on “Global Bile Duct Cancer Market Research Report - Forecast to 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

Pune, India - April 16, 2018 /MarketersMedia/ —

The Global Bile Duct Cancer Market is expected to grow at an approximate CAGR of 9.2% during the forecast period. Bile duct cancer or cholangiocarcinoma is a form of cancer in which epithelial cells are mutated, i.e., they show epithelial differentiation in the bile duct. It is a type of rare neoplasm. According to the National Cancer Institute, in 2014, there were an estimated 66,771 people living with liver and intrahepatic bile duct cancer in the United States. Moreover, the disease is expected to cause 28,920 deaths by the end of 2017 accounting for 4.8% of all cancer deaths. Rates for new liver and intrahepatic bile duct cancer cases have risen by an average 2.7% each year over the last 10 years. Death rates have been estimated to have risen by an average of 2.6% each year over 2005-2014. Such an increase in the prevalence of bile duct cancer has boosted the market. Additionally, rising healthcare expenditures, increasing awareness for the disease and investments in the R&D for treatment procedures is fuelling the market further. However, high cost of treatment and related side effects along with low healthcare expenditures in the developing economies is expected to restrain the market during the forecasted period.

Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/4741 .

Key Players in the Bile Duct Cancer Market:

Pfizer Inc. (U.S.), F. Hoffmann-La Roche Ltd (Europe), Bristol-Myers Squibb Company (U.S.), Teva Pharmaceutical Industries Ltd. (Isreal), Eli Lilly and Company. (U.S.), Sanofi (France), Fresenius Kabi AG (Germany), Mylan N.V. (U.S.), and others.

Bile Duct Cancer Market Regional Analysis:

The Americas dominates the global bile duct cancer market owing to a well-developed healthcare sector. Apart from this, increasing number of patients, increasing healthcare expenditure have boosted the growth of the market in the Americas. According to the Centers for Disease Control and Prevention, U.S. health care spending in 2015, reached $3.2 trillion or $9,990 per person which accounted for 17.8% of the total GDP.

Europe is the second largest bile duct cancer market, which is followed by Asia Pacific. Availability of funds for research, huge patient population and government support for research & development drives the European market.

Asia Pacific is the fastest growing region for the market due to the presence of a huge patient population, continuously developing economies like India and China, and presence of huge opportunity in the market. According to Indian Brand Equity Fund, the per capita healthcare expenditure in India is estimated to grow at a CAGR of 5% during 2008-15 and reach USD 68.6 by 2015.

On the other hand, the Middle East & Africa has the least share in the global bile duct cancer market due to the presence of poor economy especially in Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure.

Global Bile Duct Cancer Market Segmentation:

The Global Bile Duct Cancer Market is segmented on the basis of types, diagnosis, treatment, and end users.

On the basis of types, the market is segmented into intrahepatic, extrahepatic, and others.

On the basis of diagnosis, the market is segmented into blood tests, abdominal imaging, surgery, and others. The diagnosis segment by abdominal imaging is sub segmented into endoscopic retrograde cholangiopancreatography (ERCP), percutaneous transhepatic cholangiography (PTC), magnetic resonance cholangiopancreatography (MRCP), and others.

On the basis of treatment, the market is segmented into chemotherapy, radiotherapy, and others. The chemotherapy segment is sub segmented into 5-fluorouracil, gemcitabine, cisplatin, and others.

On the basis of end users, the market is segmented into hospital &clinics, academic institutes, research organizations and others.

Get Discount @ https://www.marketresearchfuture.com/check-discount/4741 .

Major TOC Bile Duct Cancer Market Research Report – Global Forecast Till 2023:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

TOC Continued….!

LIST OF TABLES

Table 1 Bile Duct Cancer Industry Synopsis, 2017 – 2023

Table 2 Global Bile Duct Cancer Market Estimates And Forecast, 2017 – 2023, (USD Million)

Table 3 Global Bile Duct Cancer Market By Region, 2017 – 2023, (USD Million)

Table 4 Global Bile Duct Cancer Market By Types, 2017 – 2023, (USD Million)

Table 5 Global Bile Duct Cancer Market By Diagnosis, 2017 – 2023, (USD Million)

Table 6 Global Bile Duct Cancer Market By Treatment, 2017 – 2023, (USD Million)

Table 7 Global Bile Duct Cancer Market By End Users, 2017 – 2023, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Bile Duct Cancer Market

Figure 3 Segmentation Market Dynamics For Global Bile Duct Cancer Market

Figure 4 Global Bile Duct Cancer Market Share, By Type 2016

Figure 5 Global Bile Duct Cancer Market Share, By Diagnosis 2016

Figure 6 Global Bile Duct Cancer Market Share, By Treatment 2016

Figure 7 Global Bile Duct Cancer Market Share, By End Users, 2016

Ask to Expertise @ https://www.marketresearchfuture.com/enquiry/4741 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: sales@marketresearchfuture.com
Organization: Market Research Future
Address: Market Research Future, Office No. 528, Amanora Chambers, Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: 6468459312

Source URL: https://marketersmedia.com/bile-duct-cancer-market-2018-global-trend-in-healthcare-industry-by-top-10-players-analysis-and-forecasts-till-2023-asserts-mrfr/331637

For more information, please visit https://www.marketresearchfuture.com/reports/bile-duct-cancer-market-4741

Source: MarketersMedia

Release ID: 331637

More News From The Buzz Reporters

Opera mezzo sees softer side of Dalila in 'Samson et Dalila'

Oct 16, 2018

NEW YORK — For Elina Garanca, there's a clue nestled in the score of Camille Saint-Saens' opera "Samson et Dalila" that suggests the pagan beauty has genuine feelings for the hero she has vowed to destroy. "It's just two pages, the passage right before her big aria, 'Mon coeur,' when she asks him to remember those old days when they were just two lovers sitting in front of each other," said Garanca, who is starring in a new production at the Metropolitan Opera. "The music becomes so innocent and pure and transparently light," the Latvian mezzo-soprano said in an interview....

2020 Democrats building ties to power brokers in key states

Oct 16, 2018

CONCORD, N.H. — Before he cut the $100,000 checks, Los Angeles Mayor Eric Garcetti brought the Democratic Party chairmen from Iowa, New Hampshire, South Carolina and Nevada backstage to meet late night television host Jimmy Kimmel and superstar hip-hop producer DJ Khaled. Garcetti may not be the best-known 2020 presidential prospect, but he will not be forgotten by those who lead Democratic politics in the states most responsible for picking the party's next presidential nominee. After the star-studded California fundraiser late last month that featured 10 state-party chairmen, followed by a private dinner, Garcetti issued $100,000 checks to each of...

Judge tosses Stormy Daniels' defamation suit against Trump

Oct 16, 2018

WASHINGTON — A federal judge dismissed Stormy Daniels' defamation lawsuit against President Donald Trump on Monday, saying the president made a "hyperbolic statement" against a political adversary when he tweeted about a composite sketch the porn actress' lawyer released. Daniels, whose real name is Stephanie Clifford, sued Trump in April after he said a composite sketch of a man she said threatened her in 2011 to keep quiet about an alleged affair with the real estate mogul was a "con job." Trump tweeted that the man was "nonexistent" and that Daniels was playing the "fake news media for fools." He...

Trump suggests 'rogue killers' murdered Saudi journalist

Oct 16, 2018

WASHINGTON — President Donald Trump suggested Monday that "rogue killers" could be responsible for the mysterious disappearance of Saudi journalist Jamal Khashoggi, an explanation offering U.S. ally Saudi Arabia a possible path out of a global diplomatic firestorm. The Saudis continued to deny they killed the writer, but there were indications the story could soon change. While Trump commented at the White House, Turkish crime scene investigators finally entered the Saudi consulate to comb the building where Khashoggi was last seen alive two weeks ago. Trump spoke after a personal 20-minute phone call with Saudi King Salman and as the...

Ann Curry to host TV show to solve medical mysteries

Oct 16, 2018

NEW YORK — Ann Curry is getting into the business of medical crowdsourcing on television. The former "Today" show anchor has agreed to anchor a Turner series that describes people with mysterious medical ailments, in the hope of reaching doctors or patients who have seen something similar and gotten help. Curry said Monday that she hoped real good can come from the series, tentatively titled "M.D. Live." TNT will air 10 episodes of the series sometime next year, each of them two hours.

Sign up now!